Global Demand Rises
Source Article
Celltrion wins 294.9 bln-won drug substance supply deal from global firm | Yonhap News AgencyOK SEOUL, March 17 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Tuesday it has secured a 294.9 billion-won (US$198 million) contract to supply drug substances to a global pharmaceutical company through 2029. The company currently has …
#Celltrion
#manufacturing
#capacity
#growth
#biotech
More Episodes
Language Laws In Canada #Shorts
1 week, 3 days ago
Porridge Recall Alert #Shorts
1 week, 4 days ago
HS2 Costs #Shorts
1 week, 4 days ago
New Medicine Quest #Shorts
1 week, 5 days ago
Turkey's Defence Ministry Reveals Helicopter Crash Details #Shorts
1 week, 5 days ago